Detection of HPV by in situ hybridization in thin-layer (ThinPrep) cervicovaginal samples

Tumor Biology

Volumn 32, Issue 3, 2011, Pages 603-609

  Alameda, Francesc ^a   Mariñoso, Maria Luisa ^a   Bellosillo, Beatriz ^a,c   Muset, Mercè ^a   Pairet, Silvia ^a   Soler, Imma ^a   Romero, Emilia ^a   Larrazabal, Fernando ^a,b   Carreras, Ramon ^a,b   Serrano, Sergi ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

HPV detection; HPV. In situ hybridization; Thin layer (ThinPrep) cervicovaginal samples

Indexed keywords

ADULT; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN SITU HYBRIDIZATION; INFECTION RISK; PAPANICOLAOU TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; WART VIRUS; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; UTERINE CERVIX; VAGINA SMEAR; VIROLOGY;

ADULT; CERVIX UTERI; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; VAGINAL SMEARS;

EID: 79960589204     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0159-4     Document Type: Article

References (25)

1. The Atypical Squamous Cells of Undetermined Significance/Low Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytology evidence of low-grade squamous intraepithelial lesions. Baseline data from a randomized trial. J Natl Cancer Inst. 2000;92 (5):397-402.
2. Ring M, Bolger N, O'Donell M, Malkin A, Bermingham N, Akpan E, et al. Evaluation of liquid-based cytology in cervical screening of high-risk populations: a split study of colposcopy and genito-urinary medicine populations. Cytopathology. 2002;13:152-9. (Pubitemid 34639353)
3. Schorge JO, Hossein Saboorian M, Hynan L, Ashfaq R. ThinPrep detection of cervical and endometrial adenocarcinoma. A retrospective cohort study. Cancer (Cancer Cytopathol). 2002;96:338-43. (Pubitemid 37356008)
4. Klinkhamer PJJM, Meerding WJ, Rosier PEWM, Hanselaar AGJM. Liquid-based cervical cytology. A review of the literature with methods of evidence-based medicine. Cancer (Cancer Cytopathol). 2003;99:263-71. (Pubitemid 37248373)
5. Bolick DR. Laboratory implementation of human papillomavirus testing. Arch Pathol Lab Med. 2003;127:984-90. (Pubitemid 36994859)
6. Baunoch DA. In search of a paradigm: molecular and morphologic methods for human papillomavirus. Adv Adm Lab. 2001;10 (5):1-10.
7. Hopman AHN, Theelen W, Hommelberg PPH, Kamps MAF, Herrington CS, Morrison LE, et al. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol. 2006;210:412-9. (Pubitemid 44830601)
8. Algeciras-Schmnich A, Policht F, Sitailo S, Song M, Morrison L, Sokolova I. Evaluation of quality and staining pattern of HPV infected epithelial cells in thin-layer cerviucal specimens using optimized HPV-Card assay. Cancer (Cancer Cytopathol). 2007;111:330-8.
9. Cavuslu S, Mant C, Starkey WG, Bible JM, Biswas C, Kell B, et al. Analytic sensitivities of hybrid-capture, consensus and type-specific polymerase chain reactions for the detection of human papillomavirus type 16DNA. J Med Virol. 1996;49(4):319-24. (Pubitemid 26301105)
10. Vernon SD, Unger ER, Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line brotting, and hybrid capture. J Clin Microbiol. 2000;38(2):651-5. (Pubitemid 30082658)
11. Kosel S, Burggraf S, Mommsen J, Engelhardt W, Olgemoller B. Type-specific detection of human papillomaviruses in a routine laboratory setting-improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation. Clin Chem Lab Med. 2003;41(6):787-91. (Pubitemid 36834123)
12. Nuovo GJ. Detection of human papillomavirus in papanicolau smears: correlation with pathologic findings and clinical outcome. Diagn Mol Pathol. 1998;7(3):158-63. (Pubitemid 28533557)
13. Layfiel LJ, HPV QN. DNA, testing in the triage of atypical squamous cells of undetermined significance (ASCUS). Cost comparison of two methods. Diagn Cytopathol. 2005;33(2):138-43.
14. Qureshi MN, Rudelli RD, Tubbs RR, Biscotti CV, Layfield LJ. Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV. Diagn Cytopathol. 2003;29:149-55. (Pubitemid 37071533)
15. Quredshi MN, Bolick D, Ringer PJ, Spagler FL, Zimmerman G. HPV testing in liquid cytology specimens: comparison of analytic sensitivity and specificity for in situ hybridization and chemilu-minescent nucleic acid testing. Acta Cytol. 2005;49(2):120-6. (Pubitemid 40388101)
16. Stoler MH. HPV testing in cervical cytology practice. It's all about choice. Acta Cytol. 2005;49:117-9. (Pubitemid 40388100)
17. Evans MF, Mount SL, Beatty BG, Cooper K. Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical lntraepithelial neoplasia. Mod Pathol. 2002;15(12):1339-47. (Pubitemid 35463003)
18. Birner P, Bachtiary B, Dreier B, Schindi M, Joura EA, Breitenecker G, et al. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod Pathol. 2001;14(7):702-9. (Pubitemid 32667215)
19. Sano T, Hikino T, Niwa Y, Kashiwabara K, Oyama T, Pukuda T, et al. In situ hybridization with biotinylated tyramide amplification: detection of human papillomavirus DNA in cervical neoplastic lesions. Mod Pathol. 1998;11(1):19-23. (Pubitemid 28177359)
20. Nasar Qureshi M, Rudelli RD, Ringer P. Analysis of HPV in situ hybridization assay (INFORM HPV, Ventana Medical Systems Inc.) by the automated cellular imaging systems ACIS (Chroma-Vision Medical Systems Inc). Poster accepted for presentation in 2003 USCAP.
21. Tjalma WA, Wan Waes TR, Van den Eeden LE, Bogers JJ. Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol. 2005;19(4):469-83. (Pubitemid 41263800)
22. Gallo G, Bibbo M, Bagella L, Zamparelli A, Sanseverino F, Giovanoli MR, et al. Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol. 2003;56(7):532-6. (Pubitemid 36819426)
23. Hopman AH, Kamps MA, Smedts F, Speel EJ, Herrington CS, Ramaekers FC. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV. Int J Cancer. 2005;115(3):419-28. (Pubitemid 40663746)
24. Guo M, Gong Y, Deavers M, Silva ES, Jan YJ, Cogdell DE, et al. Evaluation of commercialized in situ hybridization assay for detecting HPB DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol. 2008;46(1):274-80.
25. De Marchi Triglia R, Metze K, Zeferino LC, de Lucci de Angelo Andrade LA. HPV in situ hibridization signal patterns as a marker for cervical intraepithelial neoplasia progression. Gynecol Oncol. 2009;112:114-8.